nodes	percent_of_prediction	percent_of_DWPC	metapath
Acitretin—ALB—type 2 diabetes mellitus	0.173	1	CbGaD
Acitretin—ALB—Gliclazide—type 2 diabetes mellitus	0.0726	0.204	CbGbCtD
Acitretin—ALB—Repaglinide—type 2 diabetes mellitus	0.0683	0.192	CbGbCtD
Acitretin—ALB—Rosiglitazone—type 2 diabetes mellitus	0.057	0.16	CbGbCtD
Acitretin—ALB—Valsartan—type 2 diabetes mellitus	0.0503	0.142	CbGbCtD
Acitretin—ALB—Nateglinide—type 2 diabetes mellitus	0.0468	0.132	CbGbCtD
Acitretin—ALB—Glyburide—type 2 diabetes mellitus	0.0316	0.0889	CbGbCtD
Acitretin—ALB—Losartan—type 2 diabetes mellitus	0.0289	0.0813	CbGbCtD
Acitretin—Vitamin A—RBP4—type 2 diabetes mellitus	0.00332	0.788	CrCbGaD
Acitretin—RBP1—islet of Langerhans—type 2 diabetes mellitus	0.0027	0.0727	CbGeAlD
Acitretin—RBP1—retina—type 2 diabetes mellitus	0.00231	0.0622	CbGeAlD
Acitretin—RXRB—islet of Langerhans—type 2 diabetes mellitus	0.0023	0.0618	CbGeAlD
Acitretin—CYP26A1—liver—type 2 diabetes mellitus	0.00202	0.0545	CbGeAlD
Acitretin—RXRA—kidney—type 2 diabetes mellitus	0.00197	0.053	CbGeAlD
Acitretin—RBP1—cardiovascular system—type 2 diabetes mellitus	0.00196	0.0526	CbGeAlD
Acitretin—RBP1—kidney—type 2 diabetes mellitus	0.00191	0.0515	CbGeAlD
Acitretin—RBP1—pancreas—type 2 diabetes mellitus	0.0019	0.0511	CbGeAlD
Acitretin—RBP1—cortex of kidney—type 2 diabetes mellitus	0.00186	0.0501	CbGeAlD
Acitretin—RXRG—cardiovascular system—type 2 diabetes mellitus	0.00177	0.0476	CbGeAlD
Acitretin—RARG—retina—type 2 diabetes mellitus	0.00174	0.0469	CbGeAlD
Acitretin—RBP1—adipose tissue—type 2 diabetes mellitus	0.00172	0.0464	CbGeAlD
Acitretin—RXRB—pancreas—type 2 diabetes mellitus	0.00162	0.0435	CbGeAlD
Acitretin—RXRG—adipose tissue—type 2 diabetes mellitus	0.00156	0.0419	CbGeAlD
Acitretin—RARA—kidney—type 2 diabetes mellitus	0.00136	0.0365	CbGeAlD
Acitretin—RARG—adipose tissue—type 2 diabetes mellitus	0.0013	0.035	CbGeAlD
Acitretin—RXRA—liver—type 2 diabetes mellitus	0.00125	0.0335	CbGeAlD
Acitretin—RARA—adipose tissue—type 2 diabetes mellitus	0.00122	0.0329	CbGeAlD
Acitretin—RBP1—liver—type 2 diabetes mellitus	0.00121	0.0325	CbGeAlD
Acitretin—RARB—liver—type 2 diabetes mellitus	0.00112	0.0301	CbGeAlD
Acitretin—RXRB—liver—type 2 diabetes mellitus	0.00103	0.0277	CbGeAlD
Acitretin—RARA—liver—type 2 diabetes mellitus	0.000858	0.0231	CbGeAlD
Acitretin—Alitretinoin—CYP1A2—type 2 diabetes mellitus	0.000608	0.144	CrCbGaD
Acitretin—ALB—liver—type 2 diabetes mellitus	0.000484	0.013	CbGeAlD
Acitretin—Tretinoin—CYP3A4—type 2 diabetes mellitus	0.000284	0.0673	CrCbGaD
Acitretin—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000101	0.000401	CcSEcCtD
Acitretin—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.0001	0.0004	CcSEcCtD
Acitretin—Anorexia—Valsartan—type 2 diabetes mellitus	0.0001	0.000399	CcSEcCtD
Acitretin—Muscle spasms—Losartan—type 2 diabetes mellitus	0.0001	0.000399	CcSEcCtD
Acitretin—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.0001	0.000398	CcSEcCtD
Acitretin—Chest pain—Metformin—type 2 diabetes mellitus	9.99e-05	0.000398	CcSEcCtD
Acitretin—Myalgia—Metformin—type 2 diabetes mellitus	9.99e-05	0.000398	CcSEcCtD
Acitretin—Malaise—Irbesartan—type 2 diabetes mellitus	9.99e-05	0.000397	CcSEcCtD
Acitretin—Headache—Pioglitazone—type 2 diabetes mellitus	9.94e-05	0.000396	CcSEcCtD
Acitretin—Visual impairment—Ramipril—type 2 diabetes mellitus	9.89e-05	0.000394	CcSEcCtD
Acitretin—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	9.88e-05	0.000393	CcSEcCtD
Acitretin—Discomfort—Metformin—type 2 diabetes mellitus	9.87e-05	0.000393	CcSEcCtD
Acitretin—Fatigue—Gliclazide—type 2 diabetes mellitus	9.87e-05	0.000393	CcSEcCtD
Acitretin—Nausea—Glipizide—type 2 diabetes mellitus	9.84e-05	0.000392	CcSEcCtD
Acitretin—Vomiting—Glimepiride—type 2 diabetes mellitus	9.83e-05	0.000391	CcSEcCtD
Acitretin—Vision blurred—Losartan—type 2 diabetes mellitus	9.82e-05	0.000391	CcSEcCtD
Acitretin—Vomiting—Sitagliptin—type 2 diabetes mellitus	9.8e-05	0.00039	CcSEcCtD
Acitretin—Pain—Gliclazide—type 2 diabetes mellitus	9.79e-05	0.00039	CcSEcCtD
Acitretin—Constipation—Gliclazide—type 2 diabetes mellitus	9.79e-05	0.00039	CcSEcCtD
Acitretin—Rash—Glimepiride—type 2 diabetes mellitus	9.75e-05	0.000388	CcSEcCtD
Acitretin—Dermatitis—Glimepiride—type 2 diabetes mellitus	9.74e-05	0.000387	CcSEcCtD
Acitretin—Rash—Sitagliptin—type 2 diabetes mellitus	9.72e-05	0.000387	CcSEcCtD
Acitretin—Dermatitis—Sitagliptin—type 2 diabetes mellitus	9.71e-05	0.000386	CcSEcCtD
Acitretin—Headache—Glimepiride—type 2 diabetes mellitus	9.69e-05	0.000385	CcSEcCtD
Acitretin—Ill-defined disorder—Losartan—type 2 diabetes mellitus	9.67e-05	0.000385	CcSEcCtD
Acitretin—Cough—Irbesartan—type 2 diabetes mellitus	9.67e-05	0.000385	CcSEcCtD
Acitretin—Headache—Sitagliptin—type 2 diabetes mellitus	9.65e-05	0.000384	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	9.58e-05	0.000381	CcSEcCtD
Acitretin—Oedema—Metformin—type 2 diabetes mellitus	9.58e-05	0.000381	CcSEcCtD
Acitretin—Tinnitus—Ramipril—type 2 diabetes mellitus	9.57e-05	0.000381	CcSEcCtD
Acitretin—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	9.54e-05	0.00038	CcSEcCtD
Acitretin—Flushing—Ramipril—type 2 diabetes mellitus	9.53e-05	0.000379	CcSEcCtD
Acitretin—Angioedema—Losartan—type 2 diabetes mellitus	9.52e-05	0.000379	CcSEcCtD
Acitretin—Infection—Metformin—type 2 diabetes mellitus	9.52e-05	0.000379	CcSEcCtD
Acitretin—Insomnia—Valsartan—type 2 diabetes mellitus	9.51e-05	0.000379	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	9.47e-05	0.000377	CcSEcCtD
Acitretin—Paraesthesia—Valsartan—type 2 diabetes mellitus	9.45e-05	0.000376	CcSEcCtD
Acitretin—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	9.43e-05	0.000375	CcSEcCtD
Acitretin—Myalgia—Irbesartan—type 2 diabetes mellitus	9.43e-05	0.000375	CcSEcCtD
Acitretin—Chest pain—Irbesartan—type 2 diabetes mellitus	9.43e-05	0.000375	CcSEcCtD
Acitretin—Arthralgia—Irbesartan—type 2 diabetes mellitus	9.43e-05	0.000375	CcSEcCtD
Acitretin—Insomnia—Orlistat—type 2 diabetes mellitus	9.4e-05	0.000374	CcSEcCtD
Acitretin—Malaise—Losartan—type 2 diabetes mellitus	9.4e-05	0.000374	CcSEcCtD
Acitretin—Anxiety—Irbesartan—type 2 diabetes mellitus	9.4e-05	0.000374	CcSEcCtD
Acitretin—Hypersensitivity—Glyburide—type 2 diabetes mellitus	9.39e-05	0.000374	CcSEcCtD
Acitretin—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	9.36e-05	0.000372	CcSEcCtD
Acitretin—Somnolence—Valsartan—type 2 diabetes mellitus	9.35e-05	0.000372	CcSEcCtD
Acitretin—Paraesthesia—Orlistat—type 2 diabetes mellitus	9.33e-05	0.000371	CcSEcCtD
Acitretin—Discomfort—Irbesartan—type 2 diabetes mellitus	9.32e-05	0.000371	CcSEcCtD
Acitretin—Skin disorder—Metformin—type 2 diabetes mellitus	9.3e-05	0.00037	CcSEcCtD
Acitretin—Immune system disorder—Ramipril—type 2 diabetes mellitus	9.27e-05	0.000369	CcSEcCtD
Acitretin—Hyperhidrosis—Metformin—type 2 diabetes mellitus	9.26e-05	0.000368	CcSEcCtD
Acitretin—Dyspepsia—Valsartan—type 2 diabetes mellitus	9.26e-05	0.000368	CcSEcCtD
Acitretin—Dizziness—Bromocriptine—type 2 diabetes mellitus	9.22e-05	0.000367	CcSEcCtD
Acitretin—Dry mouth—Irbesartan—type 2 diabetes mellitus	9.22e-05	0.000367	CcSEcCtD
Acitretin—Nausea—Glimepiride—type 2 diabetes mellitus	9.18e-05	0.000365	CcSEcCtD
Acitretin—Nausea—Sitagliptin—type 2 diabetes mellitus	9.15e-05	0.000364	CcSEcCtD
Acitretin—Dyspepsia—Orlistat—type 2 diabetes mellitus	9.15e-05	0.000364	CcSEcCtD
Acitretin—Asthenia—Glyburide—type 2 diabetes mellitus	9.15e-05	0.000364	CcSEcCtD
Acitretin—Decreased appetite—Valsartan—type 2 diabetes mellitus	9.14e-05	0.000364	CcSEcCtD
Acitretin—Anorexia—Metformin—type 2 diabetes mellitus	9.13e-05	0.000363	CcSEcCtD
Acitretin—Cough—Losartan—type 2 diabetes mellitus	9.1e-05	0.000362	CcSEcCtD
Acitretin—Urticaria—Gliclazide—type 2 diabetes mellitus	9.1e-05	0.000362	CcSEcCtD
Acitretin—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	9.08e-05	0.000361	CcSEcCtD
Acitretin—Alopecia—Ramipril—type 2 diabetes mellitus	9.07e-05	0.000361	CcSEcCtD
Acitretin—Fatigue—Valsartan—type 2 diabetes mellitus	9.07e-05	0.000361	CcSEcCtD
Acitretin—Abdominal pain—Gliclazide—type 2 diabetes mellitus	9.05e-05	0.00036	CcSEcCtD
Acitretin—Body temperature increased—Gliclazide—type 2 diabetes mellitus	9.05e-05	0.00036	CcSEcCtD
Acitretin—Oedema—Irbesartan—type 2 diabetes mellitus	9.04e-05	0.00036	CcSEcCtD
Acitretin—Decreased appetite—Orlistat—type 2 diabetes mellitus	9.04e-05	0.000359	CcSEcCtD
Acitretin—Pruritus—Glyburide—type 2 diabetes mellitus	9.02e-05	0.000359	CcSEcCtD
Acitretin—Constipation—Valsartan—type 2 diabetes mellitus	8.99e-05	0.000358	CcSEcCtD
Acitretin—Infection—Irbesartan—type 2 diabetes mellitus	8.98e-05	0.000357	CcSEcCtD
Acitretin—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	8.97e-05	0.000357	CcSEcCtD
Acitretin—Fatigue—Orlistat—type 2 diabetes mellitus	8.96e-05	0.000357	CcSEcCtD
Acitretin—Erythema—Ramipril—type 2 diabetes mellitus	8.94e-05	0.000356	CcSEcCtD
Acitretin—Pain—Orlistat—type 2 diabetes mellitus	8.89e-05	0.000354	CcSEcCtD
Acitretin—Chest pain—Losartan—type 2 diabetes mellitus	8.87e-05	0.000353	CcSEcCtD
Acitretin—Arthralgia—Losartan—type 2 diabetes mellitus	8.87e-05	0.000353	CcSEcCtD
Acitretin—Myalgia—Losartan—type 2 diabetes mellitus	8.87e-05	0.000353	CcSEcCtD
Acitretin—Vomiting—Bromocriptine—type 2 diabetes mellitus	8.87e-05	0.000353	CcSEcCtD
Acitretin—Anxiety—Losartan—type 2 diabetes mellitus	8.84e-05	0.000352	CcSEcCtD
Acitretin—Rash—Bromocriptine—type 2 diabetes mellitus	8.79e-05	0.00035	CcSEcCtD
Acitretin—Dermatitis—Bromocriptine—type 2 diabetes mellitus	8.79e-05	0.00035	CcSEcCtD
Acitretin—Skin disorder—Irbesartan—type 2 diabetes mellitus	8.78e-05	0.000349	CcSEcCtD
Acitretin—Tension—Ramipril—type 2 diabetes mellitus	8.77e-05	0.000349	CcSEcCtD
Acitretin—Discomfort—Losartan—type 2 diabetes mellitus	8.77e-05	0.000349	CcSEcCtD
Acitretin—Dysgeusia—Ramipril—type 2 diabetes mellitus	8.75e-05	0.000348	CcSEcCtD
Acitretin—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	8.74e-05	0.000348	CcSEcCtD
Acitretin—Headache—Bromocriptine—type 2 diabetes mellitus	8.74e-05	0.000348	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	8.73e-05	0.000347	CcSEcCtD
Acitretin—Diarrhoea—Glyburide—type 2 diabetes mellitus	8.72e-05	0.000347	CcSEcCtD
Acitretin—Nervousness—Ramipril—type 2 diabetes mellitus	8.68e-05	0.000345	CcSEcCtD
Acitretin—Dry mouth—Losartan—type 2 diabetes mellitus	8.68e-05	0.000345	CcSEcCtD
Acitretin—Anorexia—Irbesartan—type 2 diabetes mellitus	8.62e-05	0.000343	CcSEcCtD
Acitretin—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	8.6e-05	0.000342	CcSEcCtD
Acitretin—Paraesthesia—Metformin—type 2 diabetes mellitus	8.6e-05	0.000342	CcSEcCtD
Acitretin—Muscle spasms—Ramipril—type 2 diabetes mellitus	8.59e-05	0.000342	CcSEcCtD
Acitretin—Feeling abnormal—Orlistat—type 2 diabetes mellitus	8.57e-05	0.000341	CcSEcCtD
Acitretin—Somnolence—Metformin—type 2 diabetes mellitus	8.52e-05	0.000339	CcSEcCtD
Acitretin—Oedema—Losartan—type 2 diabetes mellitus	8.51e-05	0.000338	CcSEcCtD
Acitretin—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	8.5e-05	0.000338	CcSEcCtD
Acitretin—Infection—Losartan—type 2 diabetes mellitus	8.45e-05	0.000336	CcSEcCtD
Acitretin—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	8.43e-05	0.000336	CcSEcCtD
Acitretin—Dyspepsia—Metformin—type 2 diabetes mellitus	8.43e-05	0.000335	CcSEcCtD
Acitretin—Urticaria—Valsartan—type 2 diabetes mellitus	8.36e-05	0.000332	CcSEcCtD
Acitretin—Decreased appetite—Metformin—type 2 diabetes mellitus	8.33e-05	0.000331	CcSEcCtD
Acitretin—Abdominal pain—Valsartan—type 2 diabetes mellitus	8.32e-05	0.000331	CcSEcCtD
Acitretin—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	8.29e-05	0.00033	CcSEcCtD
Acitretin—Nausea—Bromocriptine—type 2 diabetes mellitus	8.28e-05	0.00033	CcSEcCtD
Acitretin—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	8.27e-05	0.000329	CcSEcCtD
Acitretin—Fatigue—Metformin—type 2 diabetes mellitus	8.26e-05	0.000329	CcSEcCtD
Acitretin—Urticaria—Orlistat—type 2 diabetes mellitus	8.26e-05	0.000329	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	8.24e-05	0.000328	CcSEcCtD
Acitretin—Hyperhidrosis—Losartan—type 2 diabetes mellitus	8.22e-05	0.000327	CcSEcCtD
Acitretin—Body temperature increased—Orlistat—type 2 diabetes mellitus	8.22e-05	0.000327	CcSEcCtD
Acitretin—Abdominal pain—Orlistat—type 2 diabetes mellitus	8.22e-05	0.000327	CcSEcCtD
Acitretin—Asthenia—Gliclazide—type 2 diabetes mellitus	8.21e-05	0.000327	CcSEcCtD
Acitretin—Constipation—Metformin—type 2 diabetes mellitus	8.19e-05	0.000326	CcSEcCtD
Acitretin—Angioedema—Ramipril—type 2 diabetes mellitus	8.17e-05	0.000325	CcSEcCtD
Acitretin—Paraesthesia—Irbesartan—type 2 diabetes mellitus	8.12e-05	0.000323	CcSEcCtD
Acitretin—Anorexia—Losartan—type 2 diabetes mellitus	8.11e-05	0.000323	CcSEcCtD
Acitretin—Vomiting—Glyburide—type 2 diabetes mellitus	8.11e-05	0.000323	CcSEcCtD
Acitretin—Pruritus—Gliclazide—type 2 diabetes mellitus	8.1e-05	0.000322	CcSEcCtD
Acitretin—Malaise—Ramipril—type 2 diabetes mellitus	8.06e-05	0.000321	CcSEcCtD
Acitretin—Rash—Glyburide—type 2 diabetes mellitus	8.04e-05	0.00032	CcSEcCtD
Acitretin—Somnolence—Irbesartan—type 2 diabetes mellitus	8.04e-05	0.00032	CcSEcCtD
Acitretin—Dermatitis—Glyburide—type 2 diabetes mellitus	8.03e-05	0.00032	CcSEcCtD
Acitretin—Headache—Glyburide—type 2 diabetes mellitus	7.99e-05	0.000318	CcSEcCtD
Acitretin—Dyspepsia—Irbesartan—type 2 diabetes mellitus	7.96e-05	0.000317	CcSEcCtD
Acitretin—Feeling abnormal—Metformin—type 2 diabetes mellitus	7.89e-05	0.000314	CcSEcCtD
Acitretin—Decreased appetite—Irbesartan—type 2 diabetes mellitus	7.86e-05	0.000313	CcSEcCtD
Acitretin—Diarrhoea—Gliclazide—type 2 diabetes mellitus	7.83e-05	0.000312	CcSEcCtD
Acitretin—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	7.83e-05	0.000312	CcSEcCtD
Acitretin—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	7.8e-05	0.000311	CcSEcCtD
Acitretin—Cough—Ramipril—type 2 diabetes mellitus	7.8e-05	0.00031	CcSEcCtD
Acitretin—Fatigue—Irbesartan—type 2 diabetes mellitus	7.79e-05	0.00031	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	7.75e-05	0.000308	CcSEcCtD
Acitretin—Hypersensitivity—Valsartan—type 2 diabetes mellitus	7.75e-05	0.000308	CcSEcCtD
Acitretin—Pain—Irbesartan—type 2 diabetes mellitus	7.73e-05	0.000308	CcSEcCtD
Acitretin—Constipation—Irbesartan—type 2 diabetes mellitus	7.73e-05	0.000308	CcSEcCtD
Acitretin—Insomnia—Losartan—type 2 diabetes mellitus	7.69e-05	0.000306	CcSEcCtD
Acitretin—Hypersensitivity—Orlistat—type 2 diabetes mellitus	7.66e-05	0.000305	CcSEcCtD
Acitretin—Paraesthesia—Losartan—type 2 diabetes mellitus	7.64e-05	0.000304	CcSEcCtD
Acitretin—Urticaria—Metformin—type 2 diabetes mellitus	7.61e-05	0.000303	CcSEcCtD
Acitretin—Myalgia—Ramipril—type 2 diabetes mellitus	7.61e-05	0.000303	CcSEcCtD
Acitretin—Chest pain—Ramipril—type 2 diabetes mellitus	7.61e-05	0.000303	CcSEcCtD
Acitretin—Arthralgia—Ramipril—type 2 diabetes mellitus	7.61e-05	0.000303	CcSEcCtD
Acitretin—Anxiety—Ramipril—type 2 diabetes mellitus	7.58e-05	0.000302	CcSEcCtD
Acitretin—Nausea—Glyburide—type 2 diabetes mellitus	7.57e-05	0.000301	CcSEcCtD
Acitretin—Abdominal pain—Metformin—type 2 diabetes mellitus	7.57e-05	0.000301	CcSEcCtD
Acitretin—Dizziness—Gliclazide—type 2 diabetes mellitus	7.57e-05	0.000301	CcSEcCtD
Acitretin—Somnolence—Losartan—type 2 diabetes mellitus	7.56e-05	0.000301	CcSEcCtD
Acitretin—Asthenia—Valsartan—type 2 diabetes mellitus	7.55e-05	0.0003	CcSEcCtD
Acitretin—Discomfort—Ramipril—type 2 diabetes mellitus	7.52e-05	0.000299	CcSEcCtD
Acitretin—Dyspepsia—Losartan—type 2 diabetes mellitus	7.49e-05	0.000298	CcSEcCtD
Acitretin—Asthenia—Orlistat—type 2 diabetes mellitus	7.46e-05	0.000297	CcSEcCtD
Acitretin—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	7.45e-05	0.000296	CcSEcCtD
Acitretin—Pruritus—Valsartan—type 2 diabetes mellitus	7.44e-05	0.000296	CcSEcCtD
Acitretin—Dry mouth—Ramipril—type 2 diabetes mellitus	7.44e-05	0.000296	CcSEcCtD
Acitretin—Decreased appetite—Losartan—type 2 diabetes mellitus	7.4e-05	0.000294	CcSEcCtD
Acitretin—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	7.39e-05	0.000294	CcSEcCtD
Acitretin—Pruritus—Orlistat—type 2 diabetes mellitus	7.35e-05	0.000293	CcSEcCtD
Acitretin—Fatigue—Losartan—type 2 diabetes mellitus	7.33e-05	0.000292	CcSEcCtD
Acitretin—Oedema—Ramipril—type 2 diabetes mellitus	7.29e-05	0.00029	CcSEcCtD
Acitretin—Vomiting—Gliclazide—type 2 diabetes mellitus	7.28e-05	0.00029	CcSEcCtD
Acitretin—Pain—Losartan—type 2 diabetes mellitus	7.27e-05	0.000289	CcSEcCtD
Acitretin—Constipation—Losartan—type 2 diabetes mellitus	7.27e-05	0.000289	CcSEcCtD
Acitretin—Rash—Gliclazide—type 2 diabetes mellitus	7.22e-05	0.000287	CcSEcCtD
Acitretin—Dermatitis—Gliclazide—type 2 diabetes mellitus	7.21e-05	0.000287	CcSEcCtD
Acitretin—Diarrhoea—Valsartan—type 2 diabetes mellitus	7.2e-05	0.000286	CcSEcCtD
Acitretin—Urticaria—Irbesartan—type 2 diabetes mellitus	7.18e-05	0.000286	CcSEcCtD
Acitretin—Headache—Gliclazide—type 2 diabetes mellitus	7.17e-05	0.000285	CcSEcCtD
Acitretin—Body temperature increased—Irbesartan—type 2 diabetes mellitus	7.15e-05	0.000284	CcSEcCtD
Acitretin—Abdominal pain—Irbesartan—type 2 diabetes mellitus	7.15e-05	0.000284	CcSEcCtD
Acitretin—Diarrhoea—Orlistat—type 2 diabetes mellitus	7.11e-05	0.000283	CcSEcCtD
Acitretin—Skin disorder—Ramipril—type 2 diabetes mellitus	7.09e-05	0.000282	CcSEcCtD
Acitretin—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	7.05e-05	0.000281	CcSEcCtD
Acitretin—Feeling abnormal—Losartan—type 2 diabetes mellitus	7.01e-05	0.000279	CcSEcCtD
Acitretin—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	6.96e-05	0.000277	CcSEcCtD
Acitretin—Dizziness—Valsartan—type 2 diabetes mellitus	6.96e-05	0.000277	CcSEcCtD
Acitretin—Anorexia—Ramipril—type 2 diabetes mellitus	6.95e-05	0.000277	CcSEcCtD
Acitretin—Dizziness—Orlistat—type 2 diabetes mellitus	6.87e-05	0.000273	CcSEcCtD
Acitretin—Asthenia—Metformin—type 2 diabetes mellitus	6.87e-05	0.000273	CcSEcCtD
Acitretin—Nausea—Gliclazide—type 2 diabetes mellitus	6.8e-05	0.000271	CcSEcCtD
Acitretin—Pruritus—Metformin—type 2 diabetes mellitus	6.78e-05	0.00027	CcSEcCtD
Acitretin—Urticaria—Losartan—type 2 diabetes mellitus	6.76e-05	0.000269	CcSEcCtD
Acitretin—Body temperature increased—Losartan—type 2 diabetes mellitus	6.72e-05	0.000268	CcSEcCtD
Acitretin—Abdominal pain—Losartan—type 2 diabetes mellitus	6.72e-05	0.000268	CcSEcCtD
Acitretin—Vomiting—Valsartan—type 2 diabetes mellitus	6.69e-05	0.000266	CcSEcCtD
Acitretin—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	6.66e-05	0.000265	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	6.65e-05	0.000264	CcSEcCtD
Acitretin—Rash—Valsartan—type 2 diabetes mellitus	6.63e-05	0.000264	CcSEcCtD
Acitretin—Dermatitis—Valsartan—type 2 diabetes mellitus	6.63e-05	0.000264	CcSEcCtD
Acitretin—Vomiting—Orlistat—type 2 diabetes mellitus	6.61e-05	0.000263	CcSEcCtD
Acitretin—Insomnia—Ramipril—type 2 diabetes mellitus	6.6e-05	0.000262	CcSEcCtD
Acitretin—Headache—Valsartan—type 2 diabetes mellitus	6.59e-05	0.000262	CcSEcCtD
Acitretin—Diarrhoea—Metformin—type 2 diabetes mellitus	6.55e-05	0.000261	CcSEcCtD
Acitretin—Rash—Orlistat—type 2 diabetes mellitus	6.55e-05	0.000261	CcSEcCtD
Acitretin—Paraesthesia—Ramipril—type 2 diabetes mellitus	6.55e-05	0.000261	CcSEcCtD
Acitretin—Dermatitis—Orlistat—type 2 diabetes mellitus	6.55e-05	0.00026	CcSEcCtD
Acitretin—Headache—Orlistat—type 2 diabetes mellitus	6.51e-05	0.000259	CcSEcCtD
Acitretin—Asthenia—Irbesartan—type 2 diabetes mellitus	6.49e-05	0.000258	CcSEcCtD
Acitretin—Somnolence—Ramipril—type 2 diabetes mellitus	6.48e-05	0.000258	CcSEcCtD
Acitretin—Dyspepsia—Ramipril—type 2 diabetes mellitus	6.42e-05	0.000255	CcSEcCtD
Acitretin—Pruritus—Irbesartan—type 2 diabetes mellitus	6.4e-05	0.000254	CcSEcCtD
Acitretin—Decreased appetite—Ramipril—type 2 diabetes mellitus	6.34e-05	0.000252	CcSEcCtD
Acitretin—Dizziness—Metformin—type 2 diabetes mellitus	6.33e-05	0.000252	CcSEcCtD
Acitretin—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	6.3e-05	0.000251	CcSEcCtD
Acitretin—Fatigue—Ramipril—type 2 diabetes mellitus	6.29e-05	0.00025	CcSEcCtD
Acitretin—Hypersensitivity—Losartan—type 2 diabetes mellitus	6.27e-05	0.000249	CcSEcCtD
Acitretin—Nausea—Valsartan—type 2 diabetes mellitus	6.25e-05	0.000249	CcSEcCtD
Acitretin—Constipation—Ramipril—type 2 diabetes mellitus	6.24e-05	0.000248	CcSEcCtD
Acitretin—Diarrhoea—Irbesartan—type 2 diabetes mellitus	6.18e-05	0.000246	CcSEcCtD
Acitretin—Nausea—Orlistat—type 2 diabetes mellitus	6.17e-05	0.000246	CcSEcCtD
Acitretin—Asthenia—Losartan—type 2 diabetes mellitus	6.1e-05	0.000243	CcSEcCtD
Acitretin—Vomiting—Metformin—type 2 diabetes mellitus	6.09e-05	0.000242	CcSEcCtD
Acitretin—Rash—Metformin—type 2 diabetes mellitus	6.04e-05	0.00024	CcSEcCtD
Acitretin—Dermatitis—Metformin—type 2 diabetes mellitus	6.03e-05	0.00024	CcSEcCtD
Acitretin—Pruritus—Losartan—type 2 diabetes mellitus	6.02e-05	0.000239	CcSEcCtD
Acitretin—Feeling abnormal—Ramipril—type 2 diabetes mellitus	6.01e-05	0.000239	CcSEcCtD
Acitretin—Headache—Metformin—type 2 diabetes mellitus	6e-05	0.000239	CcSEcCtD
Acitretin—Dizziness—Irbesartan—type 2 diabetes mellitus	5.98e-05	0.000238	CcSEcCtD
Acitretin—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	5.96e-05	0.000237	CcSEcCtD
Acitretin—Diarrhoea—Losartan—type 2 diabetes mellitus	5.82e-05	0.000232	CcSEcCtD
Acitretin—Urticaria—Ramipril—type 2 diabetes mellitus	5.79e-05	0.000231	CcSEcCtD
Acitretin—Body temperature increased—Ramipril—type 2 diabetes mellitus	5.77e-05	0.000229	CcSEcCtD
Acitretin—Abdominal pain—Ramipril—type 2 diabetes mellitus	5.77e-05	0.000229	CcSEcCtD
Acitretin—Vomiting—Irbesartan—type 2 diabetes mellitus	5.75e-05	0.000229	CcSEcCtD
Acitretin—Rash—Irbesartan—type 2 diabetes mellitus	5.7e-05	0.000227	CcSEcCtD
Acitretin—Dermatitis—Irbesartan—type 2 diabetes mellitus	5.69e-05	0.000227	CcSEcCtD
Acitretin—Nausea—Metformin—type 2 diabetes mellitus	5.69e-05	0.000226	CcSEcCtD
Acitretin—Headache—Irbesartan—type 2 diabetes mellitus	5.66e-05	0.000225	CcSEcCtD
Acitretin—Dizziness—Losartan—type 2 diabetes mellitus	5.63e-05	0.000224	CcSEcCtD
Acitretin—Vomiting—Losartan—type 2 diabetes mellitus	5.41e-05	0.000215	CcSEcCtD
Acitretin—Hypersensitivity—Ramipril—type 2 diabetes mellitus	5.37e-05	0.000214	CcSEcCtD
Acitretin—Nausea—Irbesartan—type 2 diabetes mellitus	5.37e-05	0.000214	CcSEcCtD
Acitretin—Rash—Losartan—type 2 diabetes mellitus	5.36e-05	0.000213	CcSEcCtD
Acitretin—Dermatitis—Losartan—type 2 diabetes mellitus	5.36e-05	0.000213	CcSEcCtD
Acitretin—Headache—Losartan—type 2 diabetes mellitus	5.33e-05	0.000212	CcSEcCtD
Acitretin—Asthenia—Ramipril—type 2 diabetes mellitus	5.23e-05	0.000208	CcSEcCtD
Acitretin—Pruritus—Ramipril—type 2 diabetes mellitus	5.16e-05	0.000205	CcSEcCtD
Acitretin—Nausea—Losartan—type 2 diabetes mellitus	5.05e-05	0.000201	CcSEcCtD
Acitretin—Diarrhoea—Ramipril—type 2 diabetes mellitus	4.99e-05	0.000199	CcSEcCtD
Acitretin—Dizziness—Ramipril—type 2 diabetes mellitus	4.82e-05	0.000192	CcSEcCtD
Acitretin—Vomiting—Ramipril—type 2 diabetes mellitus	4.64e-05	0.000185	CcSEcCtD
Acitretin—Rash—Ramipril—type 2 diabetes mellitus	4.6e-05	0.000183	CcSEcCtD
Acitretin—Dermatitis—Ramipril—type 2 diabetes mellitus	4.6e-05	0.000183	CcSEcCtD
Acitretin—Headache—Ramipril—type 2 diabetes mellitus	4.57e-05	0.000182	CcSEcCtD
Acitretin—Nausea—Ramipril—type 2 diabetes mellitus	4.33e-05	0.000172	CcSEcCtD
Acitretin—RBP1—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.6e-05	8.93e-05	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—SERPINE1—type 2 diabetes mellitus	1.59e-05	8.88e-05	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—PRKCB—type 2 diabetes mellitus	1.59e-05	8.88e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—CPT1A—type 2 diabetes mellitus	1.59e-05	8.86e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—GPD2—type 2 diabetes mellitus	1.58e-05	8.84e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—CDO1—type 2 diabetes mellitus	1.58e-05	8.84e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—SLC2A2—type 2 diabetes mellitus	1.58e-05	8.83e-05	CbGpPWpGaD
Acitretin—RARB—Gene Expression—SERPINE1—type 2 diabetes mellitus	1.56e-05	8.71e-05	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—NOS3—type 2 diabetes mellitus	1.56e-05	8.7e-05	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.56e-05	8.7e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—CPT1A—type 2 diabetes mellitus	1.55e-05	8.65e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—MTR—type 2 diabetes mellitus	1.55e-05	8.65e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	1.55e-05	8.64e-05	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	1.54e-05	8.6e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	1.54e-05	8.58e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—NAMPT—type 2 diabetes mellitus	1.52e-05	8.49e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	1.51e-05	8.44e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—LIPC—type 2 diabetes mellitus	1.51e-05	8.43e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—GCK—type 2 diabetes mellitus	1.51e-05	8.43e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—HBA1—type 2 diabetes mellitus	1.51e-05	8.43e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—AK1—type 2 diabetes mellitus	1.51e-05	8.43e-05	CbGpPWpGaD
Acitretin—RBP1—Disease—TGFB1—type 2 diabetes mellitus	1.51e-05	8.43e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—RELA—type 2 diabetes mellitus	1.5e-05	8.4e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—CYP11A1—type 2 diabetes mellitus	1.5e-05	8.38e-05	CbGpPWpGaD
Acitretin—RARA—Gene Expression—SERPINE1—type 2 diabetes mellitus	1.49e-05	8.35e-05	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—SERPINE1—type 2 diabetes mellitus	1.49e-05	8.35e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	1.49e-05	8.33e-05	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—NOTCH2—type 2 diabetes mellitus	1.48e-05	8.27e-05	CbGpPWpGaD
Acitretin—RBP1—Disease—EGFR—type 2 diabetes mellitus	1.48e-05	8.26e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—SLC9A1—type 2 diabetes mellitus	1.47e-05	8.23e-05	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	1.47e-05	8.21e-05	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	1.47e-05	8.21e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—CETP—type 2 diabetes mellitus	1.46e-05	8.14e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—ADRA2A—type 2 diabetes mellitus	1.45e-05	8.1e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—TIMP1—type 2 diabetes mellitus	1.44e-05	8.07e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—PLAT—type 2 diabetes mellitus	1.44e-05	8.07e-05	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	1.43e-05	8.02e-05	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	1.43e-05	7.99e-05	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	1.43e-05	7.97e-05	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PTGS2—type 2 diabetes mellitus	1.42e-05	7.96e-05	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	1.42e-05	7.92e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—SLC5A4—type 2 diabetes mellitus	1.39e-05	7.78e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—MAT1A—type 2 diabetes mellitus	1.39e-05	7.78e-05	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—IGF1—type 2 diabetes mellitus	1.39e-05	7.78e-05	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—AKT2—type 2 diabetes mellitus	1.39e-05	7.77e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	1.39e-05	7.75e-05	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—AR—type 2 diabetes mellitus	1.38e-05	7.71e-05	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—RELA—type 2 diabetes mellitus	1.37e-05	7.65e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	1.36e-05	7.6e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	1.36e-05	7.59e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—NOS1—type 2 diabetes mellitus	1.36e-05	7.58e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.36e-05	7.58e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—SREBF1—type 2 diabetes mellitus	1.35e-05	7.56e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—SNAP25—type 2 diabetes mellitus	1.35e-05	7.56e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PSMD6—type 2 diabetes mellitus	1.35e-05	7.56e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	1.35e-05	7.54e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—ENPP1—type 2 diabetes mellitus	1.34e-05	7.51e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—HBA2—type 2 diabetes mellitus	1.34e-05	7.51e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—G6PC—type 2 diabetes mellitus	1.34e-05	7.51e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.34e-05	7.51e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—ND1—type 2 diabetes mellitus	1.34e-05	7.51e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—CTGF—type 2 diabetes mellitus	1.33e-05	7.42e-05	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—SERPINE1—type 2 diabetes mellitus	1.32e-05	7.39e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—PTPN1—type 2 diabetes mellitus	1.32e-05	7.38e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—HMGCR—type 2 diabetes mellitus	1.32e-05	7.36e-05	CbGpPWpGaD
Acitretin—ALB—Selenium Micronutrient Network—IL6—type 2 diabetes mellitus	1.31e-05	7.34e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—GCGR—type 2 diabetes mellitus	1.3e-05	7.28e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—RASGRP1—type 2 diabetes mellitus	1.3e-05	7.26e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.3e-05	7.26e-05	CbGpPWpGaD
Acitretin—RXRA—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.29e-05	7.21e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—ADRA2A—type 2 diabetes mellitus	1.29e-05	7.2e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.28e-05	7.16e-05	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—CDKN2B—type 2 diabetes mellitus	1.27e-05	7.11e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.27e-05	7.09e-05	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—PIK3R1—type 2 diabetes mellitus	1.26e-05	7.05e-05	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—SIRT1—type 2 diabetes mellitus	1.26e-05	7.03e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	1.25e-05	7.01e-05	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	1.25e-05	6.98e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—CYP2E1—type 2 diabetes mellitus	1.24e-05	6.92e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—CYTB—type 2 diabetes mellitus	1.23e-05	6.87e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—OXCT1—type 2 diabetes mellitus	1.23e-05	6.87e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—SLC2A1—type 2 diabetes mellitus	1.22e-05	6.84e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—CYP1A2—type 2 diabetes mellitus	1.22e-05	6.84e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—SRD5A1—type 2 diabetes mellitus	1.2e-05	6.7e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—CYP3A4—type 2 diabetes mellitus	1.19e-05	6.67e-05	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	1.19e-05	6.66e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.19e-05	6.64e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.18e-05	6.6e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—SOD1—type 2 diabetes mellitus	1.18e-05	6.58e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—SLC2A4—type 2 diabetes mellitus	1.17e-05	6.56e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—GCG—type 2 diabetes mellitus	1.17e-05	6.56e-05	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—MMP9—type 2 diabetes mellitus	1.17e-05	6.52e-05	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—NFKB1—type 2 diabetes mellitus	1.15e-05	6.45e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.15e-05	6.43e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—STAR—type 2 diabetes mellitus	1.14e-05	6.39e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—ACACA—type 2 diabetes mellitus	1.14e-05	6.39e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—HSD17B3—type 2 diabetes mellitus	1.14e-05	6.39e-05	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	1.14e-05	6.39e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—GNB3—type 2 diabetes mellitus	1.14e-05	6.36e-05	CbGpPWpGaD
Acitretin—RBP1—Disease—IL6—type 2 diabetes mellitus	1.14e-05	6.35e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—IGF2—type 2 diabetes mellitus	1.12e-05	6.25e-05	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—NR3C1—type 2 diabetes mellitus	1.12e-05	6.24e-05	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—PPP2CA—type 2 diabetes mellitus	1.11e-05	6.21e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—ABCC8—type 2 diabetes mellitus	1.1e-05	6.13e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—CBS—type 2 diabetes mellitus	1.1e-05	6.13e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—APOB—type 2 diabetes mellitus	1.08e-05	6.06e-05	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—SRC—type 2 diabetes mellitus	1.08e-05	6.01e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.06e-05	5.9e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—COX2—type 2 diabetes mellitus	1.05e-05	5.9e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—SLC5A2—type 2 diabetes mellitus	1.05e-05	5.9e-05	CbGpPWpGaD
Acitretin—RBP1—Disease—AKT1—type 2 diabetes mellitus	1.05e-05	5.86e-05	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—VEGFA—type 2 diabetes mellitus	1.05e-05	5.85e-05	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—PPARA—type 2 diabetes mellitus	1.05e-05	5.85e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—NCOA6—type 2 diabetes mellitus	1.04e-05	5.79e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	1.04e-05	5.79e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.04e-05	5.79e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—HSD11B1—type 2 diabetes mellitus	1.02e-05	5.69e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—UCP2—type 2 diabetes mellitus	1.02e-05	5.69e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—UCP3—type 2 diabetes mellitus	1.02e-05	5.69e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.01e-05	5.65e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—GNB3—type 2 diabetes mellitus	1.01e-05	5.65e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—HMOX1—type 2 diabetes mellitus	1.01e-05	5.63e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—CAT—type 2 diabetes mellitus	9.93e-06	5.55e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	9.87e-06	5.52e-05	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	9.85e-06	5.5e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—CD36—type 2 diabetes mellitus	9.84e-06	5.5e-05	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	9.8e-06	5.48e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—PPP2CA—type 2 diabetes mellitus	9.72e-06	5.43e-05	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	9.71e-06	5.43e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—APOB—type 2 diabetes mellitus	9.64e-06	5.39e-05	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—TGFB1—type 2 diabetes mellitus	9.61e-06	5.37e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PCK1—type 2 diabetes mellitus	9.58e-06	5.35e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	9.43e-06	5.27e-05	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—EGFR—type 2 diabetes mellitus	9.42e-06	5.27e-05	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	9.39e-06	5.25e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—GSTM1—type 2 diabetes mellitus	9.38e-06	5.24e-05	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—SRC—type 2 diabetes mellitus	9.33e-06	5.22e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—LPL—type 2 diabetes mellitus	9.21e-06	5.15e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	9.2e-06	5.14e-05	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—VEGFA—type 2 diabetes mellitus	9.09e-06	5.08e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—ADCY5—type 2 diabetes mellitus	9.01e-06	5.04e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—GPX1—type 2 diabetes mellitus	8.98e-06	5.02e-05	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—TNF—type 2 diabetes mellitus	8.98e-06	5.02e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—MMP1—type 2 diabetes mellitus	8.97e-06	5.02e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—HK1—type 2 diabetes mellitus	8.97e-06	5.01e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	8.96e-06	5.01e-05	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	8.78e-06	4.91e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—CD36—type 2 diabetes mellitus	8.75e-06	4.89e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—CALM1—type 2 diabetes mellitus	8.71e-06	4.87e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—LPA—type 2 diabetes mellitus	8.66e-06	4.84e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—GCKR—type 2 diabetes mellitus	8.66e-06	4.84e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—HSD3B2—type 2 diabetes mellitus	8.66e-06	4.84e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—KCNJ11—type 2 diabetes mellitus	8.66e-06	4.84e-05	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—PPARG—type 2 diabetes mellitus	8.64e-06	4.83e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PPP2CA—type 2 diabetes mellitus	8.64e-06	4.83e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—APOA1—type 2 diabetes mellitus	8.58e-06	4.8e-05	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—TGFB1—type 2 diabetes mellitus	8.34e-06	4.66e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	8.33e-06	4.66e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—ALDOB—type 2 diabetes mellitus	8.3e-06	4.64e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—MTHFR—type 2 diabetes mellitus	8.29e-06	4.63e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—PRKCB—type 2 diabetes mellitus	8.19e-06	4.58e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PPARA—type 2 diabetes mellitus	8.13e-06	4.55e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—NOS2—type 2 diabetes mellitus	8.09e-06	4.52e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	8.07e-06	4.51e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—IL6—type 2 diabetes mellitus	7.96e-06	4.45e-05	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	7.92e-06	4.43e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	7.9e-06	4.42e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—AGT—type 2 diabetes mellitus	7.88e-06	4.4e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	7.81e-06	4.37e-05	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—SERPINE1—type 2 diabetes mellitus	7.79e-06	4.35e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—CALM1—type 2 diabetes mellitus	7.74e-06	4.33e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—GLP1R—type 2 diabetes mellitus	7.72e-06	4.32e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—APOE—type 2 diabetes mellitus	7.72e-06	4.31e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—APOA1—type 2 diabetes mellitus	7.63e-06	4.26e-05	CbGpPWpGaD
Acitretin—RARG—Gene Expression—AKT1—type 2 diabetes mellitus	7.63e-06	4.26e-05	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	7.43e-06	4.15e-05	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.34e-06	4.1e-05	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—IL6—type 2 diabetes mellitus	7.24e-06	4.05e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—SLC2A2—type 2 diabetes mellitus	7.21e-06	4.03e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—IGF1—type 2 diabetes mellitus	7.17e-06	4.01e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—AKT2—type 2 diabetes mellitus	7.17e-06	4.01e-05	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—AKT1—type 2 diabetes mellitus	7.16e-06	4e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—MTR—type 2 diabetes mellitus	7.06e-06	3.95e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—CPT1A—type 2 diabetes mellitus	7.06e-06	3.95e-05	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—AKT1—type 2 diabetes mellitus	6.98e-06	3.9e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—NAMPT—type 2 diabetes mellitus	6.92e-06	3.87e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	6.88e-06	3.85e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—LIPC—type 2 diabetes mellitus	6.88e-06	3.85e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—HBA1—type 2 diabetes mellitus	6.88e-06	3.85e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—GCK—type 2 diabetes mellitus	6.88e-06	3.85e-05	CbGpPWpGaD
Acitretin—RARB—Gene Expression—AKT1—type 2 diabetes mellitus	6.84e-06	3.82e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—CYP11A1—type 2 diabetes mellitus	6.84e-06	3.82e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—SERPINE1—type 2 diabetes mellitus	6.81e-06	3.81e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PPARG—type 2 diabetes mellitus	6.72e-06	3.76e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—SLC9A1—type 2 diabetes mellitus	6.72e-06	3.75e-05	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—AKT1—type 2 diabetes mellitus	6.68e-06	3.74e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—CETP—type 2 diabetes mellitus	6.64e-06	3.71e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—INS—type 2 diabetes mellitus	6.59e-06	3.69e-05	CbGpPWpGaD
Acitretin—RARA—Gene Expression—AKT1—type 2 diabetes mellitus	6.56e-06	3.67e-05	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—AKT1—type 2 diabetes mellitus	6.56e-06	3.67e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—PIK3R1—type 2 diabetes mellitus	6.5e-06	3.64e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—NOS3—type 2 diabetes mellitus	6.5e-06	3.64e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—SREBF1—type 2 diabetes mellitus	6.17e-06	3.45e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PSMD6—type 2 diabetes mellitus	6.17e-06	3.45e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—SNAP25—type 2 diabetes mellitus	6.17e-06	3.45e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—CTGF—type 2 diabetes mellitus	6.06e-06	3.39e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—ALB—type 2 diabetes mellitus	6.04e-06	3.38e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—HMGCR—type 2 diabetes mellitus	6e-06	3.36e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	5.92e-06	3.31e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—ADRA2A—type 2 diabetes mellitus	5.88e-06	3.28e-05	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—AKT1—type 2 diabetes mellitus	5.8e-06	3.24e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PIK3R1—type 2 diabetes mellitus	5.78e-06	3.23e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—NOS3—type 2 diabetes mellitus	5.78e-06	3.23e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—CYP2E1—type 2 diabetes mellitus	5.64e-06	3.16e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—CYP1A2—type 2 diabetes mellitus	5.58e-06	3.12e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—SLC2A1—type 2 diabetes mellitus	5.58e-06	3.12e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—CYP3A4—type 2 diabetes mellitus	5.44e-06	3.04e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	5.42e-06	3.03e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—GCG—type 2 diabetes mellitus	5.35e-06	2.99e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—SLC2A4—type 2 diabetes mellitus	5.35e-06	2.99e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PTGS2—type 2 diabetes mellitus	5.29e-06	2.96e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—SRC—type 2 diabetes mellitus	4.81e-06	2.69e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—VEGFA—type 2 diabetes mellitus	4.69e-06	2.62e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.61e-06	2.58e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—GNB3—type 2 diabetes mellitus	4.61e-06	2.58e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—HMOX1—type 2 diabetes mellitus	4.59e-06	2.57e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—CAT—type 2 diabetes mellitus	4.53e-06	2.53e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—APOB—type 2 diabetes mellitus	4.4e-06	2.46e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—TGFB1—type 2 diabetes mellitus	4.3e-06	2.4e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—GSTM1—type 2 diabetes mellitus	4.28e-06	2.39e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—LPL—type 2 diabetes mellitus	4.2e-06	2.35e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—ADCY5—type 2 diabetes mellitus	4.11e-06	2.3e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—GPX1—type 2 diabetes mellitus	4.1e-06	2.29e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—CD36—type 2 diabetes mellitus	3.99e-06	2.23e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PPP2CA—type 2 diabetes mellitus	3.94e-06	2.2e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—MTHFR—type 2 diabetes mellitus	3.78e-06	2.11e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PPARA—type 2 diabetes mellitus	3.71e-06	2.07e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—AGT—type 2 diabetes mellitus	3.59e-06	2.01e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—CALM1—type 2 diabetes mellitus	3.53e-06	1.97e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—APOE—type 2 diabetes mellitus	3.52e-06	1.97e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—APOA1—type 2 diabetes mellitus	3.48e-06	1.95e-05	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—AKT1—type 2 diabetes mellitus	3.42e-06	1.91e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PPARG—type 2 diabetes mellitus	3.07e-06	1.71e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—INS—type 2 diabetes mellitus	3.01e-06	1.68e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—AKT1—type 2 diabetes mellitus	2.99e-06	1.67e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—AKT1—type 2 diabetes mellitus	2.66e-06	1.49e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PIK3R1—type 2 diabetes mellitus	2.64e-06	1.47e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—NOS3—type 2 diabetes mellitus	2.64e-06	1.47e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PTGS2—type 2 diabetes mellitus	2.41e-06	1.35e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—AKT1—type 2 diabetes mellitus	1.21e-06	6.78e-06	CbGpPWpGaD
